Is high-flux dialysis cost-effective?

Area of Science:

• Nephrology
• Health Economics
• Clinical Medicine

Background:

• Routine-maintenance hemodialysis is crucial for end-stage renal disease (ESRD) patients.
• High-flux dialysis presents potential benefits like shorter sessions but incurs higher equipment costs.
• Clinical and financial risks associated with high-flux dialysis require careful evaluation.

Purpose of the Study:

• To retrospectively evaluate the cost-effectiveness of high-flux dialysis versus conventional dialysis.
• To compare clinical outcomes, specifically hospital admission rates.
• To assess the impact on life expectancy and overall societal cost-effectiveness.

Main Methods:

• Retrospective analysis of patient data from a hospital-based dialysis center.
• Comparison of treatment costs between high-flux and conventional hemodialysis groups.
• Statistical adjustment for patient characteristics to determine life expectancy differences.

Main Results:

• Annual treatment costs were comparable: $31,249 (high-flux) vs. $32,562 (conventional).
• Hospital admission rates were similar: 1.24 admissions/year (high-flux) vs. 1.29 admissions/year (conventional).
• High-flux dialysis predicted a significantly higher life expectancy prolongation (1.8–4.5 years) with a cost-effectiveness ratio of $28,188 per life-year saved.

Conclusions:

• High-flux dialysis demonstrates superior societal cost-effectiveness compared to conventional dialysis.
• The increased capital investment for high-flux equipment is justifiable based on improved patient outcomes.
• High-flux dialysis is a viable and beneficial treatment option for ESRD patients.